Anticipated $0.02 EPS for Semler Scientific, Inc. (SMLR) as of May, 8

April 17, 2018 - By Elizabeth Jones

Semler Scientific, Inc. (OTCMKTS:SMLR) Corporate Logo

Semler Scientific, Inc. (OTCMKTS:SMLR)’s quarterly earnings will be published On May, 8., RTT reports. Analysts have anticipation on stock’s EPS of $0.02. That’s up 111.76 % from last year’s $-0.17 EPS. In case of $0.02 EPS SMLR’s profit could be $118,849. Wall Street sees -50.00 % negative EPS growth as of May, 8. The stock increased 0.12% or $0.01 during the last trading session, reaching $8.29.Currently Semler Scientific, Inc. is after 0.00% change in last April 17, 2017. SMLR has 1,100 shares volume. The stock underperformed the S&P 500 by 11.55%.

Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.The company has $49.26 million market cap. The Company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform that performs tests for various chronic diseases, such as respiratory disease, vascular disease, eye disease, bone disease, heart disease, neuropathy, and diabetes.Currently it has negative earnings. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.